ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

4.41
Delayed Data
As of Apr 26
 +0.09 / +2.08%
Today’s Change
3.33
Today|||52-Week Range
7.88
+6.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$618.0M

Company Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer and graft-versus-host-disease. The company was founded on September 9, 2003 and is headquartered in Boston, MA.

Contact Information

ZIOPHARM Oncology, Inc.
Parris Building
Boston Massachusetts 02129
P:(617) 259-1970
Investor Relations:

Employees

Shareholders

Individual stakeholders25.73%
Mutual fund holders18.29%
Other institutional15.20%

Top Executives

Laurence James Neil CooperChief Executive Officer
David M. MauneyExecutive VP, Chief Operating & Business Officer
Kevin G. LafondPrincipal Financial Officer & Treasurer
Francois LebelChief Medical Officer, EVP-Research & Development
Lynn M. FerrucciSVP-Human Resources, Facilities & Administration